SBU Enquiry Service has responded to questions from the National Board of Health and Welfare concerning transmission risk end effect of non-invasive ventilation in patients with covid-19 and respiratory failure during hospitalization.
- Risk for transmission of viral infection during treatment with non-invasive ventilation using CPAP or BiPAP
- Effectiveness of non-invasive ventilation in the treatment of acute respiratory failure due to coronavirus
- Risk for transmission of viral infection during treatment with nebuliser or high-flow nasal cannula